155 related articles for article (PubMed ID: 36583834)
1. Δ
Takeda S; Hirao-Suzuki M; Aramaki H; Watanabe K
Forensic Toxicol; 2023 Jul; 41(2):287-293. PubMed ID: 36583834
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Takeda S; Yamamoto I; Watanabe K
Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
[TBL] [Abstract][Full Text] [Related]
3. Failure of cannabinoid compounds to stimulate estrogen receptors.
Ruh MF; Taylor JA; Howlett AC; Welshons WV
Biochem Pharmacol; 1997 Jan; 53(1):35-41. PubMed ID: 8960061
[TBL] [Abstract][Full Text] [Related]
4. Δ(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ).
Takeda S; Yoshida K; Nishimura H; Harada M; Okajima S; Miyoshi H; Okamoto Y; Amamoto T; Watanabe K; Omiecinski CJ; Aramaki H
Chem Res Toxicol; 2013 Jul; 26(7):1073-9. PubMed ID: 23718638
[TBL] [Abstract][Full Text] [Related]
5. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.
Bonnin A; Fernández-Ruiz JJ; Martín M; Rodríguez de Fonseca F; Hernández ML; Ramos JA
J Neural Transm Gen Sect; 1993; 92(2-3):81-95. PubMed ID: 8103663
[TBL] [Abstract][Full Text] [Related]
6. Δ9-Tetrahydrocannabinol targeting estrogen receptor signaling: the possible mechanism of action coupled with endocrine disruption.
Takeda S
Biol Pharm Bull; 2014; 37(9):1435-8. PubMed ID: 25177025
[TBL] [Abstract][Full Text] [Related]
7. Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells.
von Bueren AO; Schlumpf M; Lichtensteiger W
Anticancer Res; 2008; 28(1A):85-9. PubMed ID: 18383828
[TBL] [Abstract][Full Text] [Related]
8. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
[TBL] [Abstract][Full Text] [Related]
9. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
10. Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.
Takeda S; Yamaori S; Motoya E; Matsunaga T; Kimura T; Yamamoto I; Watanabe K
Toxicology; 2008 Mar; 245(1-2):141-6. PubMed ID: 18249480
[TBL] [Abstract][Full Text] [Related]
11. Effects of Δ(9)-tetrahydrocannabinol (THC) on human amniotic epithelial cell proliferation and migration.
Yao JL; He QZ; Liu M; Chang XW; Wu JT; Duan T; Wang K
Toxicology; 2018 Feb; 394():19-26. PubMed ID: 29191629
[TBL] [Abstract][Full Text] [Related]
12. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
14. The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta.
Maia J; Almada M; Midão L; Fonseca BM; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Toxicol Sci; 2020 Oct; 177(2):420-430. PubMed ID: 32647869
[TBL] [Abstract][Full Text] [Related]
15. Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding.
Rawitch AB; Schultz GS; Ebner KE; Vardaris RM
Science; 1977 Sep; 197(4309):1189-91. PubMed ID: 897662
[TBL] [Abstract][Full Text] [Related]
16. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
McKallip RJ; Nagarkatti M; Nagarkatti PS
J Immunol; 2005 Mar; 174(6):3281-9. PubMed ID: 15749859
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression.
Yuan S; Huang C; Ji X; Ma M; Rao K; Wang Z
Ecotoxicol Environ Saf; 2018 Sep; 160():1-9. PubMed ID: 29783106
[TBL] [Abstract][Full Text] [Related]
18. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo.
Hsieh CY; Santell RC; Haslam SZ; Helferich WG
Cancer Res; 1998 Sep; 58(17):3833-8. PubMed ID: 9731492
[TBL] [Abstract][Full Text] [Related]
19. Repeated exposure to 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) accelerates ligand-independent activation of estrogen receptors in long-term estradiol-deprived MCF-7 cells.
Hirao-Suzuki M; Takiguchi M; Yoshihara S; Takeda S
Toxicol Lett; 2023 Apr; 378():31-38. PubMed ID: 36863540
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of steroidal analogs as estrogenic/anti-estrogenic agents.
Alsayari A; Kopel L; Ahmed MS; Pay A; Carlson T; Halaweish FT
Steroids; 2017 Feb; 118():32-40. PubMed ID: 27876568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
